Zhou Zheng, Sun Bao, Nie Anzheng, Yu Dongsheng, Bian Meng
Department of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Front Cell Dev Biol. 2020 Nov 27;8:599765. doi: 10.3389/fcell.2020.599765. eCollection 2020.
Aminoacyl-tRNA synthetases (ARSs) catalyze the ligation of amino acids to their cognate transfer RNAs (tRNAs), thus playing an important role in protein synthesis. In eukaryotic cells, these enzymes exist in free form or in the form of multi-tRNA synthetase complex (MSC). The latter contains nine cytoplasmic ARSs and three ARS-interacting multifunctional proteins (AIMPs). Normally, ARSs and AIMPs are regarded as housekeeping molecules without additional functions. However, a growing number of studies indicate that ARSs are involved in a variety of physiological and pathological processes, especially tumorigenesis. Here, we introduce the roles of ARSs and AIMPs in certain cancers, such as colon cancer, lung cancer, breast cancer, gastric cancer and pancreatic cancer. Furthermore, we particularly focus on their potential clinical applications in cancer, aiming at providing new insights into the pathogenesis and treatment of cancer.
氨酰-tRNA合成酶(ARSs)催化氨基酸与其对应的转运RNA(tRNAs)连接,因此在蛋白质合成中发挥重要作用。在真核细胞中,这些酶以游离形式或多tRNA合成酶复合体(MSC)的形式存在。后者包含9种细胞质ARSs和3种与ARS相互作用的多功能蛋白(AIMPs)。通常,ARSs和AIMPs被视为没有额外功能的管家分子。然而,越来越多的研究表明,ARSs参与多种生理和病理过程,尤其是肿瘤发生。在此,我们介绍ARSs和AIMPs在某些癌症(如结肠癌、肺癌、乳腺癌、胃癌和胰腺癌)中的作用。此外,我们特别关注它们在癌症中的潜在临床应用,旨在为癌症的发病机制和治疗提供新的见解。